Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (6): 584-589.doi: 10.3969/j.issn.1000-6621.2021.06.011
• Original Articles • Previous Articles Next Articles
FANG Min, SHI Yan, DUAN Li, SHI Xiao-mei, QUAN Shu-ting, WANG Ya-cui, PENG Xiao-shan, JIA Ji-hang, QI Hui, JIAO Wei-wei, ZHU Yu(), SUN Lin(
)
Received:
2021-03-09
Online:
2021-06-10
Published:
2021-06-02
Contact:
ZHU Yu,SUN Lin
E-mail:zhuyu_wj@163.com;chinatka@163.com
FANG Min, SHI Yan, DUAN Li, SHI Xiao-mei, QUAN Shu-ting, WANG Ya-cui, PENG Xiao-shan, JIA Ji-hang, QI Hui, JIAO Wei-wei, ZHU Yu, SUN Lin. Diagnostic value of GeneXpert MTB/RIF Ultra for pulmonary tuberculosis in children using gastric juice[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 584-589. doi: 10.3969/j.issn.1000-6621.2021.06.011
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.06.011
[1] | World Health Organization. Global tuberculosis report 2020. Geneva:World Health Organization, 2020. |
[2] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[3] |
Donovan J, Thu DD, Phu NH, et al. Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study. Lancet Infect Dis, 2020,20(3):299-307. doi: 10.1016/S1473-3099(19)30649-8.
doi: S1473-3099(19)30649-8 pmid: 31924551 |
[4] |
Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis, 2017,18:68-75. doi: 10.1016/S1473-3099(17)30474-7.
doi: 10.1016/S1473-3099(17)30474-7 URL |
[5] |
Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis, 2018,18:76-84. doi: 10.1016/S1473-3099(17)30691-6.
doi: S1473-3099(17)30691-6 pmid: 29198911 |
[6] |
Perez-Risco D, Rodriguez-Temporal D, Valledor-Sanchez I, et al. Evaluation of the Xpert MTB/RIF Ultra assay for direct detection of Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples. J Clin Microbiol, 2018,56:e00659-18. doi: 10.1128/JCM.00659-18.
doi: 10.1128/JCM.00659-18 |
[7] |
Nicol MP, Workman L, Prins M, et al. Accuracy of Xpert MTB/RIF Ultra for the diagnosis of pulmonary tuberculosis in children. Pediatr Infect Dis J, 2018,37(10):e261-e263. doi: 10.1097/INF.0000000000001960.
doi: 10.1097/INF.0000000000001960 URL |
[8] |
Sabi I, Rachow A, Mapamba D, et al. Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study. J Infect, 2018,77(4):321-327. doi: 10.1016/j.jinf.2018.07.002.
doi: 10.1016/j.jinf.2018.07.002 URL |
[9] |
Sun L, Qi X, Liu F, et al. A Test for More Accurate Diagnosis of Pulmonary Tuberculosis. Pediatrics, 2019,144(5):e20190262. doi: 10.1542/peds.2019-0262.
doi: 10.1542/peds.2019-0262 URL |
[10] |
Zar HJ, Workman L, Prins M, et al. Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens. Am J RespirCrit Care Med, 2019,200(12):1531-1538. doi: 10.1164/rccm.201904-0772OC.
doi: 10.1164/rccm.201904-0772OC URL |
[11] | World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization, 2014. |
[12] | World Health Organization. Non-inferiority analysis of Xpert MTB/RIF Ultra compared to Xpert MTB/RIF. Geneva: World Health Organization, 2017. |
[13] |
Chakravorty S, Simmons AM, Rowneki M, et al. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. mBio, 2017,8(4):e00812-17. doi: 10.1128/mBio.00812-17.
doi: 10.1128/mBio.00812-17 |
[14] |
Aslam W, Tahseen S, Schomotzer C, et al. Gastric specimens for diagnosing tuberculosis in adults unable to expectorate in Rawalpindi, Pakistan. Public Health Action, 2017,7(2):141-146. doi: 10.5588/pha.16.0126.
doi: 10.5588/pha.16.0126 pmid: 28695088 |
[15] |
Liu R, Liang Q, Shang Y, et al. GeneXpert of stool versus gastric lavage fluide for the diagnosis of pulmonary tuberculosis in severely ill adults. Infection, 2019,47(4):611-616. doi: 10.1007/s15010-019-01295-5.
doi: 10.1007/s15010-019-01295-5 URL |
[16] |
Fiebig L, Hauer B, Brodhun B, et al. Bacteriological confirmation of pulmonary tuberculosis in children with gastric aspirates in Germany, 2002—2010. Int J Tuberc Lung Dis, 2014,18(8):925-930. doi: 10.5588/ijtld.13.0578.
doi: 10.5588/ijtld.13.0578 URL |
[17] |
Pomputius WF 3rd, Rost J, Dennehy PH, et al. Standardization of gastric aspirate technique improves yield in the diagnosis of tuberculosis in children. Pediatr Infect Dis J, 1997,16(2):222-226. doi: 10.1097/00006454-199702000-00011.
doi: 10.1097/00006454-199702000-00011 pmid: 9041605 |
[18] |
Singh S, Singh A, Prajapati S, et al. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis. BMC Microbiol, 2015,15:191. doi: 10.1186/s12866-015-0528-z.
doi: 10.1186/s12866-015-0528-z URL |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||